Statistics
Publications
6
Citations
999
H-Index
6
Active since
2012
Marjolein de Bruijn is an author at Oncode Institute specializing in cancer immunotherapy, oncology, and cancer immunology.
Publications per year
2012–2023
6
6
Roel G. J. Klein Wolterink, Alex KleinJan, Menno van Nimwegen et al. · European Journal of Immunology · 2012 · 472 citations · Full text
An ex vivo tumor fragment platform to dissect response to PD-1 blockade in cancer
Paula Voabil, Marjolein de Bruijn, Lisanne M. Roelofsen et al. · Nature Medicine · 2021 · 369 citations
Medicine, Cancer Biology, Oncology +14
SLFN11 can sensitize tumor cells towards IFN-γ-mediated T cell killing
Riccardo Mezzadra, Marjolein de Bruijn, Lucas T. Jae et al. · PLoS ONE · 2019 · 50 citations · Full text
Life Sciences, Immunology, Oncology +17
An adverse tumor-protective effect of IDO1 inhibition
Juliana C.N. Kenski, Xinyao Huang, David W. Vredevoogd et al. · Cell Reports Medicine · 2023 · 32 citations · Full text
Life Sciences, Immunology, Oncology +17
1–5 of 6